Advertisement
Screener

BRUKER CORPORATION (BRKR) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

2.8 / 5 stars · 64/116 Roast Me

BRUKER CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

BRUKER CORPORATION (BRKR) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 38.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2025-03-03

  • BRUKER CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 38.00%, a 2.70% increase from fiscal 2023.
  • BRUKER CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 37.00%, a 2.78% increase from fiscal 2022.
  • BRUKER CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 36.00%, a 5.88% increase from fiscal 2021.
  • BRUKER CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2021 was 34.00%, a 0.00% change from fiscal 2020.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month as first filed
2024-12-3138.00%
10-K · filed 2025-03-03
2023-12-3137.00%
10-K · filed 2025-03-03
2022-12-3136.00%
10-K · filed 2025-03-03
2022-09-3036.00%
10-Q · filed 2022-11-04
2021-12-3134.00%
10-K · filed 2024-02-29
2021-09-3034.00%
10-Q · filed 2022-11-04
2020-12-3134.00%
10-K · filed 2023-03-01
34.10%
10-K · filed 2021-03-01
2020-09-3034.00%
10-Q · filed 2021-11-05
2019-12-3129.60%
10-K · filed 2022-02-28
29.57%
10-K · filed 2021-03-01
2019-09-3030.00%
10-Q · filed 2020-11-06
2018-12-3128.46%
10-K · filed 2021-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34